+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Regression of atherosclerosis demands low LDL targets and raised HDL levels



Regression of atherosclerosis demands low LDL targets and raised HDL levels



Cardiovascular Journal of Africa 19(4): 221-221




(PDF emailed within 1 workday: $29.90)

Accession: 055446818

Download citation: RISBibTeXText

PMID: 18776971


Related references

The influence of pravastatin on progression and regression of coronary atherosclerosis in men with normal or mildly raised serum cholesterol Results of the regression growth evaluation statin study. Journal of the American College of Cardiology 0(SPEC ISSUE): 281A, 1995

Atherosclerosis. Potential targets for stabilization and regression. Circulation 86(6 Suppl): Iii117-23, 1992

Atherosclerosis regression and plaque stabilization: comparison of therapeutic targets. Giornale Italiano di Cardiologia 10(11-12 Suppl 3): 13s-17s, 2011

Effect of high doses of N1-sulfanilyl-N2-n-butylcarbamide on the regression of experimental atherosclerosis, spontaneous atherosclerosis and serum cholesterol levels of male chicken. Arzneimittel-Forschung 8(5): 301-304, 1958

Reversibility of atherosclerosis--evolving perspectives from two arterial imaging clinical trials: the cholesterol lowering atherosclerosis regression study and the monitored atherosclerosis regression study. Journal of Cardiovascular Pharmacology 25 Suppl 4: S25-S31, 1995

Prospects for atherosclerosis regression through increase in high-density lipoprotein and other emerging therapeutic targets. Heart 93(5): 559-564, 2006

The Value Of Raised Serum Triglyceride Levels In The Biological Diagnosis Of Atherosclerosis. Actualites Cardiologiques et Angeiologiques Internationales 13: 35-41, 1964

Regression and therapy of atherosclerosis: regression of treated atherosclerosis viewed by coronary angiography. Nihon Rinsho. Japanese Journal of Clinical Medicine 46(3): 679-685, 1988

Lipoprotein lipase gene mutations, plasma lipid levels, progression/regression of coronary atherosclerosis, response to therapy, and future clinical events: Lipoproteins and Coronary Atherosclerosis Study. Atherosclerosis 144(2): 435-442, June, 1999

Raised MCP-4 levels in symptomatic carotid atherosclerosis: an inflammatory link between platelet and monocyte activation. Cardiovascular Research 86(2): 265-273, 2010

Effects of niacin on glucose levels, coronary stenosis progression, and clinical events in subjects with normal baseline glucose levels (<100 mg/dl): a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), HDL-Atherosclerosis Treatment Study (HATS), Armed Forces Regression Study (AFREGS), and Carotid Plaque Composition by MRI during lipid-lowering (CPC) study. American Journal of Cardiology 111(3): 352-355, 2013

Reduction of serum cholesterol levels and regression of atherosclerosis. Pathology 23(1): 45-53, 1991

Regression of atherosclerosis. Benefit can be expected from low LDL-C and high HDL-C levels. Acta Cardiologica 46(4): 431-438, 1991

The relationship between lipoprotein levels and xanthomas during progression and regression of atherosclerosis. Atherosclerosis 36(3): 351-364, 1980